These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 18972629

  • 21. Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy.
    Labbene I, Arrigo M, Tavares M, Hajjej Z, Brandão JL, Tolppanen H, Feliot E, Gayat E, Ferjani M, Mebazaa A.
    Anaesth Crit Care Pain Med; 2017 Feb; 36(1):39-42. PubMed ID: 27436451
    [Abstract] [Full Text] [Related]

  • 22. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M, Saad M, Kynast J, Geist V, Sherif MA, Richardt G, Toelg R.
    Am J Cardiol; 2010 Apr 01; 105(7):967-71. PubMed ID: 20346314
    [Abstract] [Full Text] [Related]

  • 23. Management of acute cardiac failure by intracoronary administration of levosimendan.
    Caimmi PP, Kapetanakis EI, Beggino C, Molinari C, Giustini G, Crosio E, Reposo G, Micalizzi E, Vacca G, Grossini E.
    J Cardiovasc Pharmacol; 2011 Sep 01; 58(3):246-53. PubMed ID: 21654504
    [Abstract] [Full Text] [Related]

  • 24. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B.
    Eur J Cardiothorac Surg; 2008 Aug 01; 34(2):326-31. PubMed ID: 18539040
    [Abstract] [Full Text] [Related]

  • 25. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA, González-Chon O, García-López SM, Chacón MA, Noriega-Iriondo F, Vega RE, Chávez-Tapia NC.
    Arch Cardiol Mex; 2005 Aug 01; 75(3):260-6. PubMed ID: 16294814
    [Abstract] [Full Text] [Related]

  • 26. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G.
    Acta Anaesthesiol Scand; 2003 Nov 01; 47(10):1251-6. PubMed ID: 14616323
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanical versus pharmacologic support for cardiogenic shock.
    Dhar G, Jolly N.
    Catheter Cardiovasc Interv; 2010 Mar 01; 75(4):626-9. PubMed ID: 20049971
    [Abstract] [Full Text] [Related]

  • 29. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C.
    Basic Res Cardiol; 2010 Mar 01; 105(2):155-67. PubMed ID: 19842009
    [Abstract] [Full Text] [Related]

  • 30. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 01; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 31. [Cardiogenic shock-- new therapeutic strategies].
    Andersen GØ, Eritsland J, Bjørnerheim R, Kløw NE, Jonassen A, Mangschau A.
    Tidsskr Nor Laegeforen; 2005 May 19; 125(10):1318-21. PubMed ID: 15909001
    [Abstract] [Full Text] [Related]

  • 32. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
    Simoons ML, Muskens G, Hugenholtz PG.
    Herz; 1983 Feb 19; 8(1):34-40. PubMed ID: 6832691
    [Abstract] [Full Text] [Related]

  • 33. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G, Prando MD, Parodi F, Cordero G, Sansa M, Bongo AS, Campi A, Aralda D, Dellavesa P, Aina F, Lazzero M, Cernigliaro C.
    G Ital Cardiol; 1996 Dec 19; 26(12):1385-99. PubMed ID: 9162668
    [Abstract] [Full Text] [Related]

  • 34. Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.
    Alhashemi JA.
    Br J Anaesth; 2005 Nov 19; 95(5):648-50. PubMed ID: 16143579
    [Abstract] [Full Text] [Related]

  • 35. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S.
    Cochrane Database Syst Rev; 2018 Jan 29; 1(1):CD009669. PubMed ID: 29376560
    [Abstract] [Full Text] [Related]

  • 36. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients.
    Severi L, Lappa A, Landoni G, Di Pirro L, Luzzi SJ, Caravetta P, Cipullo P, Menichetti A.
    J Cardiothorac Vasc Anesth; 2011 Aug 29; 25(4):632-6. PubMed ID: 21546269
    [Abstract] [Full Text] [Related]

  • 37. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM, Valk SD, den Uil CA, van der Ent M, Lagrand WK, van de Sande M, van Domburg RT, Simoons ML.
    Am J Cardiol; 2009 Aug 01; 104(3):327-32. PubMed ID: 19616662
    [Abstract] [Full Text] [Related]

  • 38. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M, Pignataro C, Fraticelli A, Mebazaa A.
    Ital Heart J; 2003 May 01; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [Abstract] [Full Text] [Related]

  • 39. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.
    Li JL, Xue H, Wang BS, Zhang HY, Yin LH, Shun WD, Wu Y, Wang LX.
    Med Sci Monit; 2007 Jun 01; 13(6):CR270-74. PubMed ID: 17534233
    [Abstract] [Full Text] [Related]

  • 40. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.
    Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G.
    Eur Heart J; 2005 Jul 01; 26(13):1276-83. PubMed ID: 15734771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.